News
14 February 2025
Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides in penetrating the Canadian and US markets
Read more...Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® (firocoxib), a non-steroidal anti-inflammatory drug (NSAID) used for pain and inflammation associated with osteoarthritis
Read more...13 February 2025
BioRay Pharmaceutical Co., Ltd. announced that the National Medical Products Administration (NMPA) has accepted the clinical trial
Read more...13 February 2025
PharmaTher Holdings Ltd. a specialty pharmaceutical company seeking FDA approval for ketamine, today announced that the Company
Read more...12 February 2025
INOVIO, a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases
Read more...11 February 2025
Hoth Therapeutics, Inc. a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, today announced its collaboration
Read more...10 February 2025
Vanda Pharmaceuticals Inc. today announced it will release results for the fourth quarter and full year
Read more...ADC Therapeutics SA, a commercial-stage global leader and pioneer in the field of antibody drug conjugates
Read more...6 February 2025
PharmChem, Inc. the leading provider of sweat patches to detect drugs of abuse, today announced that the Company's Board of Directors
Read more...5 February 2025
Coeptis Therapeutics Holdings, Inc. a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune
Read more...